Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Controlled Phase 3 Study.

NCT00594958 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.

NCT NCT00594958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00594958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51. Double Blind, Randomized, Controlled Phase 3 Study.
Lead sponsor
Valneva Austria GmbH
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2007
Enrollment
639 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis